Association between prolactin and disease activity in systemic lupus erythematosus.: Influence of statistical power

被引:0
|
作者
Blanco-Favela, F [1 ]
Quintal-Alvarez, G [1 ]
Leaños-Miranda, A [1 ]
机构
[1] Pediat Hosp, Natl Med Ctr Siglo XXI, Inst Mexicano Seguro Social, Res Immunol Unit, Mexico City 06725, DF, Mexico
关键词
hyperprolactinemia; SLE; disease activity; sample size; statistical power;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To analyze the statistical power of studies in the medical literature on the relationship between prolactin (PRL) and systemic lupus erythematosus (SLE) activity. Methods. Published studies that were identified through MEDLINE search, as well as references from these articles, were reviewed. Results, We identified 5 articles that sought to establish a relationship between PRL and SLE activity. In 4 of them, the frequency of hyperprolactinemia in SLE (> 20 ng/ml) was 2.2-47.2%, and in one article, there was a relationship between PRL and SLE activity. A power analysis of individual studies could be carried out in only 2 of the 5; there were no significant effects; the 2 articles cited differences in the frequency of hyperprolactinemia in patients with and without lupus activity (1.6 and 12.3%, respectively), but because of a low power of the studies (greater than or equal to 30.8%), it could not be determined whether the differences in the frequency of hyperprolactinemia were significant. On the other hand, joint analysis of 3 articles showed a significant association between hyperprolactinemia and lupus activity. Conclusion. Published clinical results concerning the relationship between PRL and lupus activity an contradictory, due in part to the statistical power of the studies. Our analysis of these studies showed that PRL is related to lupus activity, without establishing a formal causal relationship.
引用
收藏
页码:55 / 59
页数:5
相关论文
共 50 条
  • [31] Disability in systemic lupus erythematosus.
    Petri, M
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S129 - S129
  • [32] Autoantibodies in systemic lupus erythematosus.
    Hiepe, F
    Riemekasten, G
    Dorner, T
    AKTUELLE RHEUMATOLOGIE, 1996, 21 (02) : 62 - 71
  • [33] Genetics and systemic lupus erythematosus.
    Tsao B.P.
    Grossman J.M.
    Current Rheumatology Reports, 2001, 3 (3) : 183 - 190
  • [34] PROLACTIN - A STIMULATOR OF DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    WALKER, SE
    ALLEN, SH
    HOFFMAN, RW
    MCMURRAY, RW
    LUPUS, 1995, 4 (01) : 3 - 9
  • [35] Pleurisy in systemic lupus erythematosus.
    Petri, M
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S607 - S608
  • [36] Obesity in systemic lupus erythematosus.
    Utset, Tammy O.
    Laughlin, Janelle
    Schmitz, Amanda
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S279 - S280
  • [37] Pregnancy and systemic lupus erythematosus.
    Wechsler, B
    Du, LTH
    Piette, JC
    ANNALES DE MEDECINE INTERNE, 1999, 150 (05): : 408 - 418
  • [38] Prolactin modulates the disease activity of systemic lupus erythematosus accompanied by prolactinoma
    Funauchi, M
    Ikoma, S
    Enomoto, H
    Sugiyama, M
    Ohno, M
    Hamada, K
    Kanamaru, A
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1998, 16 (04) : 479 - 482
  • [39] Malignancy and systemic lupus erythematosus.
    Bernatsky S.
    Clarke A.
    Ramsey-Goldman R.
    Current Rheumatology Reports, 2002, 4 (4) : 351 - 358
  • [40] Is there an association between systemic lupus erythematosus and periodontal disease?
    Calderaro, Debora Cerqueira
    Ferreira, Gilda Aparecida
    Souza de Mendonca, Santuza Maria
    Correa, Joice Dias
    Santos, Fabricia Xavier
    Capinam Sancao, Joao Guilherme
    da Silva, Tarcilia Aparecida
    Teixeira, Antonio Lucio
    REVISTA BRASILEIRA DE REUMATOLOGIA, 2016, 56 (03) : 280 - 284